Laetitia Petersen - Concepedia

Author

Laetitia Petersen

3D-Micromac (Germany)

Also Known As

L PETERSEN, L. G. Petersen, L.J. Petersen, L.Nuchel Petersen, Laetitia Petersen

Publications

280

Citations

H-Index

Concepts

All Affiliations

3D-Micromac (Germany)

About

Laetitia Petersen is an author at 3D-Micromac (Germany) specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	189
2	Immunology	5	5	189
3	Cell Biology	4	4	175
4	Autoimmune Disease	2	2	71
5	Allergy	1	1	39

Laetitia Petersen

Publications

277

Citations

H-Index

Page 1

	Year	Citations
Therapeutic Window of MuS110, a Single-Chain Antibody Construct Bispecific for Murine EpCAM and Murine CD3 Maria Amann, Klaus Brischwein, Petra Lutterbuese, Cancer Research ImmunologyImmunodominanceImmunologic MechanismAntigen ProcessingImmunotherapeutics	2008	89
Effect of the nonsedative H1-receptor antagonist astemizole in perennial allergic and nonallergic rhinitis J.‐Å. Wihl, Bret T. Petersen, Laetitia Petersen, Journal of Allergy and Clinical Immunology	1985	67
Therapeutic window of an EpCAM/CD3-specific BiTE antibody in mice is determined by a subpopulation of EpCAM-expressing lymphocytes that is absent in humans Maria Amann, Matthias Friedrich, Petra Lutterbuese, Cancer Immunology Immunotherapy AllergyAutoimmune DiseaseLaboratory ImmunologyImmunologyImmunologic Mechanism	2008	39
A human monoclonal IgG1 potently neutralizing the pro-inflammatory cytokine GM-CSF Eva-Maria Krinner, Tobias Raum, Silke Petsch, Molecular Immunology InflammationCytokineAutoimmune DiseaseHuman Monoclonal Igg1Immune Regulation	2006	32
IL-1β-induced pro-apoptotic signalling is facilitated by NCAM/FGF receptor signalling and inhibited by the C3d ligand in the INS-1E rat beta cell line Laetitia Petersen, Joachim Størling, Peter E. Heding, Diabetologia InflammationIl-1β-induced Pro-apoptotic SignallingNcam/fgf Receptor SignallingCytokineSignal Transduction	2006	15
Exchanging human Fcγ1 with murine Fcγ2a highly potentiates anti-tumor activity of anti-EpCAM antibody adecatumumab in a syngeneic mouse lung metastasis model Petra Lutterbuese, Klaus Brischwein, Robert Hofmeister, Cancer Immunology Immunotherapy Murine Fcγ2aCancer ImmunosurveillanceMedicineImmunologyTumor Immunity	2006	14
Discovery and development of ANV419, an IL-2/anti-IL-2 antibody fusion protein with potent CD8+ T and natural killer cell-stimulating capacity for cancer immunotherapy Patrizia Murer, Barbara Brannetti, Jean‐Michel Rondeau, mAbs	2024	11
Enhanced immunogenic potential of cancer immunotherapy antibodies in human IgG1 transgenic mice Jérôme Egli, Stefan Heiler, Felix Weber, mAbs	2022	10

Page 1